|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$13,747||Benefits minus costs||$43,845|
|Participants||$24,055||Benefit to cost ratio||$612.03|
|Others||$4,114||Chance the program will produce|
|Indirect||$2,001||benefits greater than the costs||100 %|
|Net program cost||($72)|
|Benefits minus cost||$43,845|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Clinical diagnosis of an anxiety disorder (e.g., general anxiety, panic, social anxiety, obsessive compulsive disorder) or symptoms measured on a validated scale.
Major depressive disorder
Clinical diagnosis of major depression or symptoms measured on a validated scale.
How well individuals (typically those who are developmentally disabled or seriously mentally ill) have adapted to activities of daily living.
Clinical diagnosis of post-traumatic stress disorder (PTSD) or symptoms measured on a validated scale.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Major depressive disorder||Mortality associated with depression||$1||$3||$0||$44||$48|
|Post-traumatic stress||Labor market earnings associated with PTSD||$9,760||$22,925||$0||$0||$32,685|
|Health care associated with PTSD||$3,986||$1,127||$4,114||$1,993||$11,220|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($36)||($36)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$974||2014||Present value of net program costs (in 2018 dollars)||($72)|
|Comparison costs||$830||2008||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Boudewyns, P.A., Stwertka, S.A., Hyer, L.A., Albrecht, J.W., & Sperr, E.V. (1993). Eye movement desensitization for PTSD of combat: A treatment outcome pilot study. The Behavior Therapist, 16(2), 29-33.
Carlson, J.G., Chemtob, C.M., Rusnak, K., Hedlund, N.L., & Muraoka, M.Y. (1998). Eye Movement Desensitization and Reprocessing (EDMR) treatment for combat-related posttraumatic stress disorder. Journal of Traumatic Stress, 11(1), 3-24.
Högberg, G., Pagani, M., Sundin, O., Soares, J., Åberg-Wistedt, A., Tärnell, B., & Hällström, T. (2007). On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers—A randomized controlled trial. Nordic Journal of Psychiatry, 61(1), 54-61.
Jensen, J.A. (1994). An investigation of eye movement desensitization and reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behavior Therapy, 25(2), 311-325.
Johnson, D.R., & Lubin, H. (2006). The counting method: Applying the rule of parsimony to the treatment of posttraumatic stress disorder. Traumatology, 12(1), 83-99.
Marcus, S.V., Marquis, P., & Sakai, C. (1997). Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy: Theory, Research, Practice, Training, 34(3), 307-315.
Rothbaum, B.O., Austin, M.C., & Marsteller, F. (2005). Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic Stress: Publ. for the Society for Traumatic Stress Studies, 18(6), 607-616.
Rothbaum, B.O. (1997). Acontrolled study of eye movement desensitization and reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bulletin of the Menninger Clinic, 61(3), 317-334.
Taylor, S., Thordarson, D.S., Maxfield, L., Fedoroff, I.C., Lovell, K., & Ogrodniczuk, J. (2003). Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. Journal of Consulting and Clinical Psychology, 71(2), 330-338.
van den Berg, D.P.G., de Bont, P.A.J.M, Berber M.v.d.V, de Roos, C., de Jongh, A., Van Minnen, A., & van der Gaag, M. (2015). Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. Jama Psychiatry, 72(3), 259-67.
van der Kolk, B.A., Spinazzola, J., Blaustein, M.E., Hopper, J.W., Hopper, E.K., Korn, D.L., & Simpson, W.B. (2007). A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. The Journal of Clinical Psychiatry, 68(1), 37-46.